(3R,4S)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate, 97.0%, 250mg

(4S,4'S)-4,4'-Di((S)-sec-butyl)-1,1'-bis(3-(tert-butyl)phenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

tert-butyl 4-[(2E)-3-(dimethylamino)prop-2-enoyl]piperidine-1-carboxylate, 5g

(3-(4-Methylpiperidine-1-carbonyl)phenyl)boronic acid, 95%, 250mg

DL-SULFORAPHANE, 95.0%, 10mg

Imidazo[1,2-a]pyrimidine-2-carboxylic acid ethylester, 95.0%, 5g

Tissue-Clearing Reagent iTOMEI-M (RI 1.40) [for Plants]25mL

9,9-Dimethyl-2,7-bis[N-(m-tolyl)anilino]fluorene>98.0%(HPLC)(N)200mg

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 500m2/g)25g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-benzaldehyde, 95.0%, 100g

4'-(trans-4-Pentylcyclohexyl)-[1,1'-biphenyl]-4-carbonitrile, 98%, 25g

4-Bromo-2-fluoro-5-methylbenzoic acid, 95.0%, 1g

2,2-Diethoxy-N,N-dimethylethanamine, 95.0%, 1g